| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/26/2023 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Stock Option (Right to Buy) | 30k | $1.32 | $39.6k | | 05/26/2023 |
| 05/26/2023 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Common Stock | 25k | $0.00 | $0 | | 05/26/2023 |
| 01/09/2023 | ATHERSYS, INC / NEW | ATHX | Grant | Common Stock | 22.3k | $0.00 | $0 | | 01/09/2023 |
| 09/16/2022 | ATHERSYS, INC / NEW | ATHX | Grant | Common Stock | 12.8k | $0.00 | $0 | | 09/16/2022 |
| 09/16/2022 | ATHERSYS, INC / NEW | ATHX | Grant | Stock Option (right to purchase) | 32k | $1.95 | $62.5k | | 09/16/2022 |
| 05/20/2022 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Common Stock | 25k | $0.00 | $0 | | 05/20/2022 |
| 05/20/2022 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Stock Option (Right to Buy) | 30k | $2.01 | $60.3k | | 05/20/2022 |
| 01/31/2022 | SELLAS Life Sciences Group, Inc. | SLS | Grant | Stock Option (Right to Buy) | 7.1k | $5.34 | $38k | | 01/31/2022 |
| 01/31/2022 | SELLAS Life Sciences Group, Inc. | SLS | Grant | Common Stock | 1.9k | $0.00 | $0 | | 01/31/2022 |
| 06/15/2021 | ATHERSYS, INC / NEW | ATHX | Grant | NonQualified Stock Option (right to purchase) | 50k | $1.54 | $77k | | 06/15/2021 |
| 05/19/2021 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Common Stock | 25k | $0.00 | $0 | | 05/19/2021 |
| 05/19/2021 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Stock Option (Right to Buy) | 30k | $3.64 | $109.2k | | 05/19/2021 |
| 03/04/2021 | SELLAS Life Sciences Group, Inc. | SLS | Grant | Stock Option (Right to Buy) | 7.5k | $8.00 | $60k | | 03/04/2021 |
| 11/12/2020 | ATHERSYS, INC / NEW | ATHX | Grant | NonQualified Stock Option (right to purchase) | 100k | $1.88 | $188k | | 11/12/2020 |
| 05/15/2020 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Stock Option (Right to Buy) | 55k | $1.77 | $97.1k | | 05/15/2020 |
| 03/12/2020 | SELLAS Life Sciences Group, Inc. | SLS | Grant | Stock Option (Right to Buy) | 6.5k | $1.89 | $12.3k | | 03/12/2020 |
| 12/02/2019 | Acorda Therapeutics, Inc. | ACOR | Sale | Common Stock | 2.2k | $1.60 | $3.6k | | 12/02/2019 |
| 11/07/2019 | Acorda Therapeutics, Inc. | ACOR | Grant | Employee Stock Option (right to buy) | 80k | $2.41 | $192.8k | | 11/07/2019 |
| 05/23/2019 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Stock Option (Right to Buy) | 13.8k | $2.02 | $27.8k | | 05/23/2019 |
| 04/01/2019 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Stock Option ( Right to Buy) | 80k | $2.42 | $193.6k | | 04/01/2019 |
| 03/14/2019 | SELLAS Life Sciences Group, Inc. | SLS | Grant | Stock Option (Right to Buy) | 25k | $1.38 | $34.5k | | 03/14/2019 |
| 03/08/2019 | Acorda Therapeutics, Inc. | ACOR | Grant | Common Stock | 12.8k | $0.00 | $0 | | 03/08/2019 |
| 03/08/2019 | Acorda Therapeutics, Inc. | ACOR | Grant | Employee Stock Option (right to buy) | 21.4k | $13.51 | $288.5k | | 03/08/2019 |
| 02/21/2019 | Acorda Therapeutics, Inc. | ACOR | Payment of Exercise | Common Stock | 953 | $13.38 | $12.8k | | 02/21/2019 |
| 12/22/2018 | Acorda Therapeutics, Inc. | ACOR | Grant | Common Stock | 2.5k | $0.00 | $0 | | 12/22/2018 |
| 12/03/2018 | Acorda Therapeutics, Inc. | ACOR | Sale | Common Stock | 3.1k | $20.52 | $62.9k | | 12/03/2018 |
| 11/05/2018 | Acorda Therapeutics, Inc. | ACOR | Payment of Exercise | Common Stock | 955 | $20.28 | $19.4k | | 11/05/2018 |
| 09/10/2018 | Acorda Therapeutics, Inc. | ACOR | Grant | Common Stock | 2.5k | $0.00 | $0 | | 09/10/2018 |
| 06/12/2018 | SELLAS Life Sciences Group, Inc. | SLS | Grant | Stock Option (Right to Buy) | 5.5k | $5.23 | $28.8k | | 06/12/2018 |
| 03/13/2018 | SELLAS Life Sciences Group, Inc. | SLS | Grant | Stock Option (Right to Buy) | 11k | $5.24 | $57.6k | | 03/13/2018 |
| 03/08/2018 | Acorda Therapeutics, Inc. | ACOR | Payment of Exercise | Common Stock | 2.5k | $25.65 | $63.4k | | 03/08/2018 |
| 03/05/2018 | Acorda Therapeutics, Inc. | ACOR | Payment of Exercise | Common Stock | 2.3k | $25.95 | $59k | | 03/05/2018 |
| 03/05/2018 | Acorda Therapeutics, Inc. | ACOR | Exercise | Employee Stock Option (right to buy) | 3k | $19.81 | $59k | | 03/05/2018 |
| 02/22/2018 | Acorda Therapeutics, Inc. | ACOR | Grant | Common Stock | 6.5k | $0.00 | $0 | | 02/22/2018 |
| 01/19/2018 | Acorda Therapeutics, Inc. | ACOR | Exercise | Employee Stock Option (right to buy) | 34.5k | $19.81 | $683.8k | | 01/19/2018 |
|